These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19040323)

  • 1. Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer.
    Banal F; Briot K; Ayoub G; Dougados M; Roux C
    J Rheumatol; 2008 Dec; 35(12):2458-9. PubMed ID: 19040323
    [No Abstract]   [Full Text] [Related]  

  • 2. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
    El Saghir NS; Otrock ZK; Bleik JH
    BMC Cancer; 2005 Dec; 5():156. PubMed ID: 16332258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute anterior uveitis associated with the use zoledronic acid].
    Cavallasca JA; Reyt C
    Medicina (B Aires); 2014; 74(5):428-9. PubMed ID: 25347912
    [No Abstract]   [Full Text] [Related]  

  • 4. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
    Belliveau MJ; Almeida DR; Urton TE
    Can J Ophthalmol; 2012 Oct; 47(5):e22-3. PubMed ID: 23036555
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid for cancer therapy--induced and postmenopausal bone loss.
    Brufsky AM
    Expert Opin Pharmacother; 2008 Apr; 9(6):1013-28. PubMed ID: 18377343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
    Doggrell SA
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
    Moore MM; Beith JM
    Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
    Jun JH
    Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
    [No Abstract]   [Full Text] [Related]  

  • 11. Zoledronic acid induced unilateral anterior uveitis.
    Gupta S; Onkar A; Vashisht T
    Indian J Ophthalmol; 2020 Sep; 68(9):2002-2003. PubMed ID: 32823458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy.
    Durnian JM; Olujohungbe A; Kyle G
    Eye (Lond); 2005 Feb; 19(2):221-2. PubMed ID: 15258605
    [No Abstract]   [Full Text] [Related]  

  • 13. Serious ocular complications of zoledronate.
    Woo TC; Joseph DJ; Wilkinson R
    Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):545-6. PubMed ID: 16969985
    [No Abstract]   [Full Text] [Related]  

  • 14. A case report: zoledronic acid-induced anterior uveitis.
    Kilickap S; Ozdamar Y; Altundag MK; Dizdar O
    Med Oncol; 2008; 25(2):238-40. PubMed ID: 18488162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral uveitis with vitreous haze following zoledronic Acid therapy for osteoporosis.
    Freitas-Neto CA; de Oliveira Fagundes WB; Ribeiro M; Pacheco KD; Freitas LG; Ávila MP
    Semin Ophthalmol; 2015 May; 30(3):232-4. PubMed ID: 24168214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
    Umunakwe OC; Herren D; Kim SJ; Kohanim S
    Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma.
    Missotten G; Verheezen Y
    Bull Soc Belge Ophtalmol; 2010; (315):23-4. PubMed ID: 21110506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.
    Med Lett Drugs Ther; 2009 Jun; 51(1315):49. PubMed ID: 19556940
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy.
    Bhoopalam N; Campbell SC; Moritz T; Broderick WR; Iyer P; Arcenas AG; Van Veldhuizen PJ; Friedman N; Reda D; Warren S; Garewal H
    J Urol; 2009 Nov; 182(5):2257-64. PubMed ID: 19758618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A once-yearly IV bisphosphonate for osteoporosis.
    Obstet Gynecol; 2008 May; 111(5):1208-9. PubMed ID: 18448761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.